RDY:NYSE
Dr Reddy's Laboratories Ltd
$12.19
0.00%
(0.00) 1D
$12.00
arrow_downward
-1.58% (-0.19)bedtimeAfter hours
Closed: Sep 18, 4:00:03 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RDY...
Open
$12.18
High
$12.26
Low
$12.14
Mkt. cap
10.20B
Avg. vol.
2.64M
Volume
1.89M
Dividend
0.68%
Quarterly dividend
$0.02
Ex-dividend date
Jul 10, 2026
P/E ratio
29.43
52-wk high
$15.67
52-wk low
$11.36
EPS
$0.41
Beta
0.30
Shares outstanding
834.64M
No. of employees
28K
Open
$12.18
High
$12.26
Low
$12.14
Mkt. cap
10.20B
Avg. vol.
2.64M
Volume
1.89M
Dividend
0.68%
Quarterly dividend
$0.02
Ex-dividend date
Jul 10, 2026
P/E ratio
29.43
52-wk high
$15.67
52-wk low
$11.36
EPS
$0.41
Beta
0.30
Shares outstanding
834.64M
No. of employees
28K
News stories
From web sources and news partners
AD HOC NEWS
·
10 hours ago
Dr Reddy's Laboratories stock gains attention on QDENGA vaccine deal
TipRanks
·
1 day ago
Dr. Reddy’s, Takeda Seal Exclusive Deal to Launch First Approved Dengue Vaccine in India’s Private Market
Investing.com
·
1 day ago
Dr Reddy’s to distribute Takeda’s dengue vaccine in India
CNBC TV18
·
1 day ago
Dr Reddy's shares gain 2% after Takeda dengue vaccine distribution deal
Profile
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
About Dr Reddy's Laboratories Ltd
CEOErez Israeli
Employees27.5K
Founded1984
HeadquartersHyderabad, Andhra Pradesh, India
SectorPharmaceutical industry
Websitedrreddys.com